Cart
sales@molnova.com
Azide-PEG12-Tos
CAS No. 1821464-56-5
Azide-PEG12-Tos( —— )
Catalog No. M26890 CAS No. 1821464-56-5
Azide-PEG12-Tos is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 28 | In Stock |
|
| 5MG | 46 | In Stock |
|
| 10MG | 66 | In Stock |
|
| 25MG | 112 | In Stock |
|
| 50MG | 161 | In Stock |
|
| 100MG | 239 | In Stock |
|
| 200MG | 353 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAzide-PEG12-Tos
-
NoteResearch use only, not for human use.
-
Brief DescriptionAzide-PEG12-Tos is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
-
DescriptionAzide-PEG12-Tos is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.(In Vitro):PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
-
In VitroPROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorBRD4
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1821464-56-5
-
Formula Weight725.85
-
Molecular FormulaC31H55N3O14S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCc1ccc(cc1)S(=O)(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCN=[N+]=[N-]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Yao, Zhiyi. BRD4 small molecule inhibitor with antitumor activity and its preparation. CN107721975A
molnova catalog
related products
-
ML265
ML265 is a potent PKM2 activator (AC50 : 92 nM) showing little or no effect on PKM1 PKL and PKRinduces tetramerization and reduces tumor formation and size in a mouse xenograft model.?.
-
MID-1
MID-1 is an inhibitor of MG53-IRS-1 (Mitsugumin 53-Insulin Receptor Substrate-1) interaction.?It disrupts molecular association of MG53 with IRS-1 and abolishes MG53-induced IRS-1 ubiquitination and degradation in skeletal muscle, leading to elevated IRS-1 expression level and increased insulin signaling and glucose uptake.
-
Dodecanedioic acid d...
Dodecanedioic acid is a dicarboxylic acid which is water-soluble and involves in a metabolic pathway intermediate to those of lipids and carbohydrates.
